南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

MCT4介导的乳酸外排促进STING依赖性树突状细胞抗肿瘤免疫反应

MCT4-mediated lactate efflux promotes STING-dependent dendritic cell antitumor immunity

Rui Ding, Yaqing Yuan, Tongchang Xu, Jingwen Zhang, Yi Zhu, Bing Yao, Shuang Qu, Zhilin Hu

Journal:Cell Reports

IF:7.7

DOI:10.1016/j.celrep.2026.117778

PMID:42541722

Published:2026-08-01

research field:生物制造药物筛选生物医学工程再生医学微流控技术纤维化研究组织工程

Abstract

The mechanisms by which DCs evolutionarily adapt to lactate accumulation to maintain their functions remain largely elusive. Here, our study highlights the MCT4-lactate axis as an intrinsic metabolic checkpoint governing intratumoral DC activity. Intratumoral lactate supplementation impedes DC-dependent antitumor activity. Additionally, we observe that MCT4 is highly expressed in intratumoral DCs and mediates lactate efflux to boost DC function. Pharmacological or genetic inhibition of MCT4 suppresses DC antitumor responses. Mechanistically, MCT4-controlled lactate efflux sustains STING signaling and STING-dependent antitumor immunity. Loss of MCT4 in DCs augments lactate accumulation, subsequently reducing intracellular pH and disrupting the interaction between G3BP1 and cGAS, ultimately leading to impaired dsDNA sensing by cGAS. Importantly, the MCT4-lactate axis supports STING-dependent DC activity in ccRCC patient samples. Our findings uncover how intratumoral DCs adapt to lactate and suggest that targeting the MCT4-lactate axis represents a promising cancer immunotherapy strategy.

本文使用的Yeasen产品

购物车
客服
转染试用